Clinical Trial Update: Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia

View source ↗

Summary

A clinical trial sponsored by EndoCore Lab s.r.l. is evaluating peripheral extreme revascularization in no-option patients with chronic limb-threatening ischemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb-threatening Ischemia
• Diabetic Foot
• Peripheral Arterial Disease

Snippet

Sponsor: EndoCore Lab s.r.l. | Conditions: Peripheral Arterial Disease, Critical Limb-Threatening Ischemia | Status: RECRUITING